A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease

Annals of Neurology

Volumn 47, Issue 3, 2000, Pages 399-403

  Papassotiropoulos, Andreas ^a   Bagli, Metin ^a   Kurz, Alexander ^b   Kornhuber, Johannes ^c   Förstl, Hans ^b   Maier, Wolfgang ^a   Pauls, Jutta ^c   Lautenschlager, Nicola ^b   Heun, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CATHEPSIN D;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; CATHEPSIN D; FEMALE; GENOTYPE; HUMANS; MALE; RISK FACTORS;

EID: 0034049387     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200003)47:3<399::AID-ANA22>3.0.CO;2-5     Document Type: Article

References (21)

1. Sisodia SS, Price DL. Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 1995;9:366-370
2. De Jonghe C, Zehr C, Yager D, et al. Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion. Neurobiol Dis 1998;5:281-286
3. De Strooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998;391:387-390
4. Lichtenthaler SF, Ida N, Multhaup G, et al. Mutations in the transmembrane domain of APP altering gamma-secretase specificity. Biochemistry 1997;36:15396-15403
5. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and trearment opportunities. Neurology 1998;51(Suppl 1):2-17
6. 2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 1999;46:382-390
7. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease: Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 1998;338:506-511
8. Montoya SE, Aston CE, DeKosky ST, et al. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet 1998;18:211-212
9. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 1997; 17:6142-6151
10. Chevallier N, Vizzavona J, Marambaud P, et al. Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res 1997; 750:11-19
11. McDermott JR, Gibson AM. Degradation of Alzheimer's betaamyloid protein by human cathepsin D. Neuroreport 1996;7: 2163-2166
12. Evin G, Cappai R, Li QX, et al. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid; possible involvement of cathepsin D. Biochemistry 1995;34:14185-14192
13. Saftig P, Peters C, von Figura K, et al. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 1996;271:27241-27244
14. Citron M, Teplow DB, Selkoe DJ. Generation of amyloid beta protein from its precursor is sequence specific. Neuron 1995; 14:661-670
15. Touitou I, Capony F, Brouiller JP, Rochefort H. Missense polymorphism (C/T224) in the human cathepsin D profragment determined by polymerase chain reaction-single strand conformational polymorphism analysis and possible consequences in cancer cells. Eur J Cancer 1994;30A:390-394
16. Papassotiropoulos A, Bagli M, Feder O, er al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease. Neurosci Lett 1999; 262:171-174
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HbaI. J Lipid Res 1990;31:545-548
19. Kenessey A, Nacharaju P, Ko LW, Yen SH. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem 1997;69:2026-2038
20. Peraus GC, Masters CL, Beyreuther K. Late compartments of amyloid precursor protein transport in SY5Y cells are involved in beta-amyloid secretion. J Neurosci 1997;17:7714-7724
21. Cataldo AM, Hamilton DJ, Barnett JL, et al. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 1996;16:186-199